Pricing Log in Create free account

PainReform Ltd. (PRFX) vs Petros Pharmaceuticals, Inc. (PTPI)

PainReform Ltd. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $2.6M against $1.0M — 2.5× the size. Across the 8 metrics below, PainReform Ltd. leads on 4 and Petros Pharmaceuticals, Inc. on 4.

Valuation

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S n/m n/m 2.11
P/B 0.00 n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA 0.97 n/m 12.58
EV/Sales n/m 0.40 2.73
Earnings yield (73,121.23%) 0.00% (4.38%)
Free cash flow yield (95,565.78%) 0.00% 0.00%

Profitability

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 76.35% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (710.28%) (0.40%)
Return on assets 0.00% (334.15%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 36.07% 10.01%
EPS growth (last fiscal year) 92.92% 98.13% 49.06%
Revenue growth, 5-year CAGR — (19.98%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 5.07 1.25 2.31
Net debt to EBITDA 0.96 1.11 0.97

Dividend

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Market cap 2.57m 1.04m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack